Jamie L. Reynoso Clover Health Investments, Corp. (CLOV) insider trading activity

Jamie L. Reynoso is CEO, Medicare Advantage of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 3.24 Million shares of CLOV, which is worth approximately $9.78 Million. The most recent transaction as insider was on Jan 03, 2024, when has been sold 26,240 shares (Class A Common Stock) at a price of $0.92 per share, resulting in proceeds of $24,140. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.24M

1.45% 3M change

31.24% 12M change

Total Value Held $9.78 Million

Jamie L. Reynoso Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2024	SELL Payment of exercise price or tax liability	$24,140 $0.92 p/Share	26,240 Reduced 1.04%	2,502,140 Class A Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$1,481 $0.95 p/Share	1,559 Reduced 0.06%	2,528,380 Class A Common Stock
Dec 15 2023	SELL Payment of exercise price or tax liability	$8,604 $0.99 p/Share	8,691 Reduced 0.34%	2,529,825 Class A Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$12,567 $1.0 p/Share	12,567 Reduced 0.49%	2,538,516 Class A Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	-	600,000 Added 19.04%	2,551,083 Class A Common Stock
Sep 15 2023	SELL Payment of exercise price or tax liability	$24,307 $1.13 p/Share	21,511 Reduced 1.09%	1,951,083 Class A Common Stock
Sep 14 2023	SELL Payment of exercise price or tax liability	$8,786 $1.13 p/Share	7,776 Reduced 0.39%	1,972,594 Class A Common Stock
Sep 07 2023	SELL Payment of exercise price or tax liability	$69,386 $1.31 p/Share	52,967 Reduced 2.6%	1,980,370 Class A Common Stock
Sep 07 2023	BUY Grant, award, or other acquisition	-	652,452 Added 24.29%	2,033,337 Class A Common Stock
Jun 14 2023	SELL Payment of exercise price or tax liability	$7,309 $0.94 p/Share	7,776 Reduced 0.56%	1,380,885 Class A Common Stock
Mar 14 2023	SELL Payment of exercise price or tax liability	$29,253 $0.93 p/Share	31,455 Reduced 2.21%	1,388,661 Class A Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$1,703 $1.33 p/Share	1,281 Reduced 0.09%	1,420,116 Class A Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$16,532 $1.01 p/Share	16,369 Reduced 1.14%	1,421,397 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	353,982 Added 19.57%	1,454,877 Class A Common Stock
Sep 16 2022	BUY Grant, award, or other acquisition	-	353,356 Added 24.3%	1,100,895 Class A Common Stock
Mar 14 2022	BUY Grant, award, or other acquisition	-	510,948 Added 40.6%	747,539 Class A Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	15,771 Added 6.25%	236,591 Class A Common Stock
Jan 07 2022	SELL Payment of exercise price or tax liability	$50,022 $3.16 p/Share	15,830 Reduced 1.09%	1,437,766 Class A Common Stock
Jul 16 2021	BUY Grant, award, or other acquisition	-	220,820 Added 50.0%	220,820 Class A Common Stock

JLR

Jamie L. Reynoso

CEO, Medicare Advantage

Franklin, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Value

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

Operation

Value

Type

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV

Account